✦ LIBER ✦

Neurocognitive function in patients with idiopathic restless legs syndrome (IRLS) before and after treatment with dopamino-agonist

✍ Scribed by Ferini Strambi, L.; Marelli, S.; Galbiati, A.; Giarolli, L.; Oldani, A.; Zucconi, M.

Book ID: 122179258
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 45 KB
Volume: 14
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2013.11.264

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Major depression after withdrawing dopam

Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders

✍ Launois, Claire; Leu-Semenescu, Smaranda; Brion, Agnès; Arnulf, Isabelle 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Controlled withdrawal of pramipexole aft

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome

✍ Claudia Trenkwalder; Karin Stiasny-Kolster; Andreas Kupsch; Wolfgang H. Oertel; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Although dopamine agonists are becoming first‐line therapy for restless legs syndrome (RLS), few reports describe treatment periods exceeding 12 weeks. Here, 150 RLS patients who had responded to pramipexole during a 6‐month run‐in period (mean dose, 0.50 mg) were randomly assigned to r

Opioid treatment is efficacious in the s

Opioid treatment is efficacious in the short- and long-term in patients with severe restless legs syndrome after failure of previous medications

✍ Trenkwalder, C.; Benes, H.; Garcia-Borreguero, D.; Grote, L.; Hopp, M.; Kohnen, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB